ESC 365 - On mid-term, had mid-range ejection fraction heart failure the same prognosis with reduced ejection fraction heart failure?

HFA Premium Access

On mid-term, had mid-range ejection fraction heart failure the same prognosis with reduced ejection fraction heart failure?

Session: Poster Session 3 - Chronic Heart Failure – Pathophysiology and Mechanisms

Topic: Heart Failure with Mid-Range Ejection Fraction (HFmrEF)

Speaker: Doctor C. Goidescu (Cluj Napoca, RO)

Event: Heart Failure 2019

Congress Presentation

Add to my library

About the speaker

Doctor Cerasela Mihaela Goidescu

Iuliu Hatieganu University of Medicine and Pharmacy, Cluj Napoca (Romania)

0 follower

42 more presentations in this session

Endomyocardial injections of autologous mesenchymal stem cell for treatment the patients with non-ischemic cardiomyopathy

Speaker: Professor A. Kurlianskaya (Minsk, BY)

Altered number of apoptotic-modified endothelial cells originated micro vesicles predict phenotypes of heart failure

Speaker: Professor A. Berezin (Salzburg, AT)

The plastics of atrioventricular valve in patients with chronic heart failure and severe left ventricular dysfunction

Speaker: Doctor O. Shatova (Minsk, BY)

Population pharmacokinetics and pharmacodynamics of vericiguat in heart failure patients with reduced ejection fraction

Speaker: Doctor M. Meyer (Wuppertal, DE)

Slow and steady wins the race- the managment of tachycardia induced cardiomyopathy

Speaker: Ms C. Farrell (Letterkenny, IE)

Access the full session

Poster Session 3 - Chronic Heart Failure – Pathophysiology and Mechanisms

Speakers: Doctor C. Goidescu, Professor A. Kurlianskaya, Professor A. Berezin, Doctor O. Shatova, Doctor M. Meyer...

About the event

Heart Failure 2019

25 May - 28 May 2019

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources